Peptide
PT-141 (Bremelanotide)
Desire's neural switch
A melanocortin receptor agonist that works centrally in the brain to enhance sexual desire. FDA-approved for hypoactive sexual desire disorder.
Mechanisms
- MC4R agonism
- Central nervous system action
- Dopamine pathway modulation
Dosing
Typical dose
1–2mg
Timing
Administer 45 minutes before desired effect. Limit to 8 doses per month.